Matthew H.J. Kim, who founded Vigilant Biosciences, and serves as the company’s chairman and CEO, is shown with Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype. Vigilant is working on an early detection system for risk of oral cancer.
Matthew H.J. Kim, who founded Vigilant Biosciences, and serves as the company’s chairman and CEO, is shown with Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype. Vigilant is working on an early detection system for risk of oral cancer. PATRICK FARRELL MIAMI HERALD STAFF
Matthew H.J. Kim, who founded Vigilant Biosciences, and serves as the company’s chairman and CEO, is shown with Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype. Vigilant is working on an early detection system for risk of oral cancer. PATRICK FARRELL MIAMI HERALD STAFF